Search research articles
Contact Us
Filters
Showing results (41-50 of 237) with videos related to
Page
of 24
Sort By:
Archives of Gynecology and Obstetrics
|
June 14, 2021
Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
Lena Steinkasserer, Delmarko Irmgard, Tatjana Weiss, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 22, 2017
L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer
Samira Abdel Azim, Susanne Sprung, Irene Mutz-Dehbalaie, et al.
Anticancer Research
|
October 15, 2010
Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer
Birgit Volgger, Katharina Kurz, Kathrin Zöschg, et al.
Cancer Biology & Therapy
|
May 25, 2006
Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF
Daniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Gynecologic Oncology
|
March 23, 2007
Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab
Christian Marth, Daniel Egle, Doris Auer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2025
Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer
Katharina Steger, Heidelinde Fiegl, Barin Feroz, et al.
Gynecologic Oncology
|
April 25, 2012
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie, Daniel Egle, Siegfried Fessler, et al.
Breast (Edinburgh, Scotland)
|
December 6, 2007
Disseminated tumor cells: are they ready for clinical use?
Stephan Braun, Florian D Vogl, Alois Schneitter, et al.
Gynecologic Oncology Reports
|
March 5, 2026
Highlighting the molecular refinement of NSMP endometrial cancer in a case of mesonephric-like adenocarcinoma
Katharina Steger, Simon Schnaiter, Sigurd Lax, et al.
Gynecologic Oncology
|
February 9, 2023
An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer
Verena Wieser, Irina Tsibulak, Daniel Uwe Reimer, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 237) with videos related to
Sort By:
Page
of 24
Archives of Gynecology and Obstetrics
|
June 14, 2021
Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
Lena Steinkasserer, Delmarko Irmgard, Tatjana Weiss, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 22, 2017
L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer
Samira Abdel Azim, Susanne Sprung, Irene Mutz-Dehbalaie, et al.
Anticancer Research
|
October 15, 2010
Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer
Birgit Volgger, Katharina Kurz, Kathrin Zöschg, et al.
Cancer Biology & Therapy
|
May 25, 2006
Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF
Daniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Gynecologic Oncology
|
March 23, 2007
Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab
Christian Marth, Daniel Egle, Doris Auer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2025
Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer
Katharina Steger, Heidelinde Fiegl, Barin Feroz, et al.
Gynecologic Oncology
|
April 25, 2012
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie, Daniel Egle, Siegfried Fessler, et al.
Breast (Edinburgh, Scotland)
|
December 6, 2007
Disseminated tumor cells: are they ready for clinical use?
Stephan Braun, Florian D Vogl, Alois Schneitter, et al.
Gynecologic Oncology Reports
|
March 5, 2026
Highlighting the molecular refinement of NSMP endometrial cancer in a case of mesonephric-like adenocarcinoma
Katharina Steger, Simon Schnaiter, Sigurd Lax, et al.
Gynecologic Oncology
|
February 9, 2023
An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer
Verena Wieser, Irina Tsibulak, Daniel Uwe Reimer, et al.
Page
of 24